Profile
Georg V.
Beiske is the founder of Tribune Therapeutics AB, founded in 2020, where the title held is Chief Executive Officer.
The current job is Venture Partner at HealthCap AB, starting in 2021.
Former job includes Development Manager at Bayer AS.
Education includes a graduate degree from the University of Oslo, conferred in 2013.
Georg Beiske active positions
| Companies | Position | Start |
|---|---|---|
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Private Equity Investor | 2021-05-31 |
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Operates as preclinical biopharmaceutical company that develops medicines to treat patients with fibrotic diseases | Chief Executive Officer | 2019-12-31 |
Former positions of Georg Beiske
| Companies | Position | End |
|---|---|---|
Bayer AS
Bayer AS Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Corporate Officer/Principal | - |
Training of Georg Beiske
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Finance |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer AS
Bayer AS Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Operates as preclinical biopharmaceutical company that develops medicines to treat patients with fibrotic diseases | Commercial Services |
- Stock Market
- Insiders
- Georg Beiske
















